Skip to main content
Start of content

INDU Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

43rd Parliament, 2nd Session
Meeting 20
Thursday, February 25, 2021, 11:04 a.m. to 1:04 p.m.
Webcast
Presiding
Sherry Romanado, Chair (Liberal)

Library of Parliament
• Sarah Lemelin-Bellerose, Analyst
• Francis Lord, Analyst
Precision Nanosystems
• Andrew Booth, Chairman
• James Taylor, Chief Executive Officer
Medicago Inc.
• Takashi Nagao, President and Chief Executive Officer
• Nicolas Petit, Vice-President, Commercial Operations
Office of the Chief Science Advisor
• Mona Nemer, Chief Science Advisor
As an individual
• Gary Kobinger, Professor, Université Laval
• Brian Lichty, Associate Professor, McMaster University
• Karen Mossman, Vice-President, Research, McMaster University
Pursuant to Standing Order 108(2) and the motion adopted by the committee on Tuesday, December 1, 2020, the committee resumed its study of domestic manufacturing capacity for a COVID-19 vaccine.

The witnesses made statements and answered questions.

At 1:04 p.m., the committee adjourned to the call of the Chair.



Michael MacPherson
Clerk of the Committee